Operating Lease, Right-of-Use Asset of Indivior Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Indivior Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Indivior Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $26,000,000, a 33% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Indivior Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $26,000,000 -$13,000,000 -33% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $30,000,000 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $35,000,000 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $37,000,000 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $39,000,000 -$1,000,000 -2.5% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $40,000,000 31 Dec 2023 10-K 03 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.